Skip to content

Do integrase inhibitors raise the risk of obesity?

High prevalence of diabetes and pre-diabetes in people at London HIV clinics

Image: Andrey_Popov/Shutterstock.com

Treatment with modern antiretrovirals doesn't increase the risk of hypertension

PrEP does not raise lipids or alter body fat, safety study finds

Diabetes in people with HIV over 50 overwhelmingly linked to old antiretrovirals, not age or body weight

Lipids improved by switching from ritonavir to cobicistat as a booster for darunavir

Switching from efavirenz to raltegravir leads to significant improvements in fatty liver disease in people with HIV

Non-alcoholic fatty liver disease common in people living with HIV – metabolic disorders are key risk factors

High prevalence of low testosterone among younger and middle-aged ART-treated men in France